The Safety and Efficacy of Second-line Single Docetaxel (75 mg/m<sup>2</sup>) Therapy in Advanced Non-Small Cell Lung Cancer Patients who were Previously Treated with Platinum-based Chemotherapy
Article in Cancer Research and Treatment (December 2005)